Prestige Consumer Healthcare, Inc. (PBH)
58.13
+1.08
(+1.89%)
USD |
NYSE |
Apr 17, 16:00
58.10
-0.03
(-0.05%)
After-Hours: 20:00
Prestige Consumer Healthcare EPS Diluted (Quarterly) : 0.9711 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Abbott Laboratories | 0.6165 |
| Eli Lilly & Co. | 7.024 |
| Amneal Pharmaceuticals, Inc. | 0.1069 |
| Crinetics Pharmaceuticals, Inc. | -1.292 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 46.70M |
| Revenue (Quarterly) | 283.44M |
| Total Expenses (Quarterly) | 236.75M |
| Enterprise Value | 3.768B |
| Gross Profit Margin (Quarterly) | 53.70% |
| Profit Margin (Quarterly) | 16.47% |
| Earnings Yield | 6.51% |
| Operating Earnings Yield | 11.68% |
| Normalized Earnings Yield | 6.805 |